Technology

BUFFERZONE Security Joins Trust.AI Consortium to Enhance AI-Based Cybersecurity Technologies

Published

2 years ago

February 29, 2024

TEL AVIV, Israel, Feb. 29, 2024 /PRNewswire/ — BUFFERZONE®, a pioneer in prevention-based cybersecurity solutions, is proud to announce its latest strategic move: joining the prestigious Trust.AI consortium. Trust.AI, funded by the Israeli Innovation Authority (IIA), is at the forefront of adversarial AI and AI confidence research, bringing together industry giants and academic leaders to pioneer advancements in artificial intelligence and cybersecurity.

The consortium boasts an impressive lineup of industry leaders, including Elbit Systems, DeepKeep, Razor Labs, Ceva Technologies Ltd, Radcom, and Cognata, as well as leading academic institutes: Ariel University, Ben-Gurion University, and Tel Aviv University. BUFFERZONE’s inclusion in this esteemed group underscores its commitment to staying at the cutting edge of AI-driven cybersecurity.

BUFFERZONE’s scope within Trust.AI is to focus on Adversarial AI advanced security. This initiative aims to bolster the defenses of its NoCloud™ AI anti-phishing technology, ensuring it remains impervious to sophisticated AI attacks that seek to bypass deep learning-based cybersecurity measures.

BUFFERZONE® has recently unveiled its groundbreaking NoCloud™ AI anti-phishing technology, which leverages innovative endpoint CPU acceleration. This innovative approach significantly enhances the speed and efficiency of phishing detection and ensures no sensitive or personal data is uploaded into the cloud.

“Joining Trust.AI is a significant milestone for BUFFERZONE®. It aligns perfectly with our vision of harnessing the power of AI to combat increasingly complex cyber threats,” said Dr. Ran Dubin, CTO of BUFFERZONE®. “Our collaboration with leading industry and academic minds will undoubtedly lead to groundbreaking developments in AI security.”

The IIA investment in Trust.AI consortium members have significantly enhanced Israeli leadership in AI security. The consortium members develop state-of-the-art detection and protection solutions against the most advanced adversarial attacks in the industry. BUFFERZONE Security technologies help the consortium tasks to make the internet safer.

BUFFERZONE’s participation in Trust-AI is expected to yield substantial advancements in AI security, particularly in enhancing the resilience of anti-phishing technologies against advanced AI threats. This collaboration marks a pivotal step in BUFFERZONE’s journey towards a safer digital world, powered by innovative and trustworthy AI.

For more information about BUFFERZONE® and its innovative cybersecurity solutions, please visit www.buffer.zone.

About BUFFERZONE®

BUFFERZONE® is a leading cybersecurity specializing in cyberattack prevention and AI anti-phishing solutions. BUFFERZONE’s NoCloudTM is the industry-first AI anti-phishing technology that uses advanced endpoint CPU acceleration to detect phishing attacks without compromising user privacy.

Contact Information:

Media Contact:

Loren Rozenbloom
Marketing Manager
BUFFERZONE Security
loren.rozenbloom@bufferzonesecurity.com
+972.3.644.4012

View original content:https://www.prnewswire.com/news-releases/bufferzone-security-joins-trustai-consortium-to-enhance-ai-based-cybersecurity-technologies-302075556.html

SOURCE BUFFERZONE

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

5 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

5 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

5 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated